Skip to content
healthcare.dev

Buprenorphine HCl and Naloxone HCl

NDC 50268-145, Buprenorphine and Naloxone, tablet, from AvPAK.

Product NDC
50268-145
Status
Listed
Labeler
AvPAK
Dosage form
TABLET
Route
SUBLINGUAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA203136
DEA schedule
CIII
Request
curl https://api.healthcare.dev/v1/drugs/ndc/50268-145 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BUPRENORPHINE HYDROCHLORIDE8 mg/1
  • NALOXONE HYDROCHLORIDE DIHYDRATE2 mg/1

Pharmacologic classes

Opioid Antagonist [EPC]; Opioid Antagonists [MoA]; Partial Opioid Agonist [EPC]; Partial Opioid Agonists [MoA]

Package NDCNDC-11Package
50268-145-155026801451550 BLISTER PACK in 1 BOX, UNIT-DOSE (50268-145-15) / 1 TABLET in 1 BLISTER PACK (50268-145-11)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/b955054b-b37d-4079-4fed-5939b763ecb4
  • NADAC price for package 50268014515

    GET /v1/drugs/nadac/50268014515

Use it

Look up 50268-145 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/50268-145 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 50268-145. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.